EMA consults on trial database transparency challenge
This article was originally published in Scrip
Executive Summary
In the latest stage in the EU's efforts to widen the publication of clinical trial data, the European Medicines Agency has opened a public consultation on how to decide exactly what information should be available in the future clinical trials database, which will be accessible to the general public.